Durata Therapeutics, Inc. Assets, Fair Value Disclosure
Durata Therapeutics, Inc. had Assets, Fair Value Disclosure of $7.80 million as of 2014-09-30, per its 10-Q filed 2014-11-07.
Discontinued › Notes › Fair Value Disclosures
us-gaap:AssetsFairValueDisclosure · last filed 2014-11-07
- 2014-09-30: Assets, Fair Value Disclosure $7.80M.
- 2014-06-30: Assets, Fair Value Disclosure $13.81M.
- 2014-03-31: Assets, Fair Value Disclosure $20.87M.
- 2013-12-31: Assets, Fair Value Disclosure $22.88M.
| Period end | Assets, Fair Value Disclosure | Assets, Fair Value Disclosure as first filed |
|---|---|---|
| 2014-09-30 | $7.80M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $13.81M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $20.87M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $22.88M 10-Q · filed 2014-11-07 | |
| 2013-09-30 | $22.11M 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $22.09M 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $14.09M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $13.09M 10-K · filed 2014-03-14 | $13.09M 10-K · filed 2013-03-08 |